According to a report from Benzinga on May 30th, the Health Department of Costa Rica has issued resolution number MS-DM-RC-2381-2024, which prohibits the import, sale, and commercialization of e-cigarettes and related products, specifically e-liquid products containing synthetic nicotine or cannabinoids.
This preventive measure has sparked discussions and reactions within the affected industry. The ban went into effect immediately after its announcement and will remain in place until the Ministry of Health releases technical regulations regarding the use and commercialization of these products.
In 2022, Bill 10.113 was passed, allowing for the import and use of cannabis products for medical and therapeutic purposes, as well as for the use of cannabis in food and industrial applications.
According to reports, the e-cigarette market in Costa Rica is still in its developmental stage. The ban has changed the business and entrepreneurial landscape for the industry, potentially causing losses for those involved and requiring the Ministry of Health to introduce clear new guidelines.
According to industry experts in Costa Rica, the decision requires additional technical regulation beyond what is established in Law No. 10.113. This means that while the importation of marijuana products is allowed, the use of consumption devices is not permitted until new standards are set.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
